SZSE:300254 (China)
Â
Class A
Â¥
9.56
(+0.74%)
May 10
Business Description
Shanxi C&Y Pharmaceutical Group Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000016D0
Share Class Description:
SZSE:300254: Class ACompare
Compare
Traded in other countries / regions
300254.China IPO Date
2011-08-19Description
Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 4.06 | |||||
| Interest Coverage | 1.83 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.56 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.9 | |||||
| 3-Year EPS without NRI Growth Rate | 61.2 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.15 | |||||
| 9-Day RSI | 56.65 | |||||
| 14-Day RSI | 54.52 | |||||
| 6-1 Month Momentum % | -1.09 | |||||
| 12-1 Month Momentum % | 64.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | |||||
| Quick Ratio | 0.65 | |||||
| Cash Ratio | 0.29 | |||||
| Days Inventory | 171.27 | |||||
| Days Sales Outstanding | 42.07 | |||||
| Days Payable | 61.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | 2.13 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.64 | |||||
| Operating Margin % | 5.86 | |||||
| Net Margin % | 5.67 | |||||
| FCF Margin % | 0.59 | |||||
| ROE % | 7.86 | |||||
| ROA % | 2.96 | |||||
| ROIC % | 3.27 | |||||
| ROC (Joel Greenblatt) % | 29.13 | |||||
| ROCE % | 10.06 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 50.58 | |||||
| PE Ratio without NRI | 72.42 | |||||
| Price-to-Owner-Earnings | 207.83 | |||||
| PS Ratio | 2.86 | |||||
| PB Ratio | 3.74 | |||||
| Price-to-Tangible-Book | 24.14 | |||||
| Price-to-Free-Cash-Flow | 478 | |||||
| Price-to-Operating-Cash-Flow | 28.88 | |||||
| EV-to-EBIT | 25.39 | |||||
| EV-to-EBITDA | 25.39 | |||||
| EV-to-Revenue | 3.22 | |||||
| EV-to-FCF | 542.91 | |||||
| Price-to-Projected-FCF | 3.51 | |||||
| Price-to-Median-PS-Value | 1.36 | |||||
| Price-to-Graham-Number | 8.85 | |||||
| Earnings Yield (Greenblatt) % | 3.94 | |||||
| FCF Yield % | 0.21 | |||||
| Forward Rate of Return (Yacktman) % | -15.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanxi C&Y Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 805.613 | ||
| EPS (TTM) (Â¥) | 0.189 | ||
| Beta | 1.09 | ||
| Volatility % | 43.79 | ||
| 14-Day RSI | 54.52 | ||
| 14-Day ATR (Â¥) | 0.686865 | ||
| 20-Day SMA (Â¥) | 9.0025 | ||
| 12-1 Month Momentum % | 64.85 | ||
| 52-Week Range (Â¥) | 4.98 - 11.6 | ||
| Shares Outstanding (Mil) | 241.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanxi C&Y Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanxi C&Y Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanxi C&Y Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254)'s stock price today?
The current price of SZSE:300254 is ¥9.56. The 52 week high of SZSE:300254 is ¥11.60 and 52 week low is ¥4.98.
When is next earnings date of Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254)?
The next earnings date of Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) is .
Does Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) pay dividends? If so, how much?
Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers